Cell Point (India) Ltd.
•₹ 15.251.67%
2026-08-21
PROS
- Company generates healthy free cash flow
- Company converts assets efficiently - asset turnover of 2.4x
CONS
- Receivables are growing faster than sales - a possible quality concern
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (55.2% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.08x)
- Interest coverage is weak at 1.5x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 289.30 | 1462.10 | 4124.61 | 1220.81 | 20.14 | 11.97 |
| 12. | CELLPOINT | 16.00 | 0.00 | 29.90 | 0.00 | — | — | — | — | 6.65 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 278 | 223 | 269 | 296 | 321 | 325 | |
| 268 | 215 | 258 | 278 | 313 | 317 | |
| Operating Profit | 10 | 8 | 12 | 19 | 10 | 9 |
| OPM % | 4 | 4 | 4 | 7 | 3 | 3 |
| Other Income | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 6 | 6 | 8 | 9 | 6 | 5 |
| Depreciation | 2 | 1 | 1 | 1 | 2 | 3 |
| 2 | 1 | 2 | 10 | 3 | 3 | |
| Tax % | 33 | 46 | 32 | 32 | 38 | 20 |
| Net Profit | 2 | 1 | 2 | 7 | 2 | 2 |
| EPS | 0 | 0 | 14 | 5 | 1 | 1 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 28 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 13 | 6 | 13 | 5 | 1 | 1 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 13 | 6 | 13 | 5 | 1 | 1 |
Mar 2020
- 278
- 268
- Operating Profit
- 10
- OPM %
- 4
- Other Income
- 1
- Interest
- 6
- Depreciation
- 2
- 2
- Tax %
- 33
- Net Profit
- 2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2021
- 223
- 215
- Operating Profit
- 8
- OPM %
- 4
- Other Income
- 1
- Interest
- 6
- Depreciation
- 1
- 1
- Tax %
- 46
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2022
- 269
- 258
- Operating Profit
- 12
- OPM %
- 4
- Other Income
- 1
- Interest
- 8
- Depreciation
- 1
- 2
- Tax %
- 32
- Net Profit
- 2
- EPS
- 14
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2023
- 296
- 278
- Operating Profit
- 19
- OPM %
- 7
- Other Income
- 1
- Interest
- 9
- Depreciation
- 1
- 10
- Tax %
- 32
- Net Profit
- 7
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 321
- 313
- Operating Profit
- 10
- OPM %
- 3
- Other Income
- 2
- Interest
- 6
- Depreciation
- 2
- 3
- Tax %
- 38
- Net Profit
- 2
- EPS
- 1
- Dividend Payout %
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 325
- 317
- Operating Profit
- 9
- OPM %
- 3
- Other Income
- 2
- Interest
- 5
- Depreciation
- 3
- 3
- Tax %
- 20
- Net Profit
- 2
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 3%
- 3 Years:
- 6%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 7%
- 3 Years:
- 11%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -33%
- 1 Year:
- -18%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 13%
- 3 Years:
- 16%
- Last Year:
- 3%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - |
| Equity Capital | 1 | 1 | 1 | 14 | 19 | 19 |
| 10 | 11 | 12 | 6 | 53 | 56 | |
| 7 | 13 | 32 | 38 | 47 | 44 | |
| Trade Payables | 12 | 10 | 13 | 11 | 9 | 14 |
| 25 | 29 | 24 | 25 | 6 | 6 | |
| Total Liabilities | 55 | 64 | 83 | 94 | 134 | 138 |
| ASSETS | - | - | - | - | - | - |
| 19 | 19 | 19 | 18 | 33 | 37 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 |
| 0 | 0 | 0 | 0 | 0 | 1 | |
| 20 | 26 | 38 | 46 | 55 | 64 | |
| 0 | 0 | 0 | 0 | 0 | 1 | |
| Cash & Bank | 3 | 3 | 8 | 10 | 12 | 6 |
| 13 | 16 | 18 | 19 | 33 | 28 | |
| Total Assets | 55 | 64 | 83 | 94 | 134 | 138 |
| Total Debt | 29 | 39 | 52 | 56 | 49 | 45 |
| Net Working Capital | 8 | 2 | 1 | 4 | 11 | 16 |
| Contingent Liabilities | 0 | 0 | 1 | 2 | 1 | 1 |
| Book Value per Share | 96.89 | 102.96 | 117.44 | 14.71 | 38.60 | 39.74 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 29 | 39 | 52 | 56 | 49 | 45 |
| Net Working Capital | 8 | 2 | 1 | 4 | 11 | 16 |
| Contingent Liabilities | 0 | 0 | 1 | 2 | 1 | 1 |
| Book Value per Share | 96.89 | 102.96 | 117.44 | 14.71 | 38.60 | 39.74 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2020
- Equity Capital
- 1
- 10
- 7
- Trade Payables
- 12
- 25
- Total Liabilities
- 55
- 19
- Capital Work in Progress
- 0
- 0
- 20
- 0
- Cash & Bank
- 3
- 13
- Total Assets
- 55
- Total Debt
- 29
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 96.89
- Face Value
- 10.00
- Total Debt
- 29
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 96.89
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 1
- 11
- 13
- Trade Payables
- 10
- 29
- Total Liabilities
- 64
- 19
- Capital Work in Progress
- 0
- 0
- 26
- 0
- Cash & Bank
- 3
- 16
- Total Assets
- 64
- Total Debt
- 39
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 102.96
- Face Value
- 10.00
- Total Debt
- 39
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 102.96
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 1
- 12
- 32
- Trade Payables
- 13
- 24
- Total Liabilities
- 83
- 19
- Capital Work in Progress
- 0
- 0
- 38
- 0
- Cash & Bank
- 8
- 18
- Total Assets
- 83
- Total Debt
- 52
- Net Working Capital
- 1
- Contingent Liabilities
- 1
- Book Value per Share
- 117.44
- Face Value
- 10.00
- Total Debt
- 52
- Net Working Capital
- 1
- Contingent Liabilities
- 1
- Book Value per Share
- 117.44
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 14
- 6
- 38
- Trade Payables
- 11
- 25
- Total Liabilities
- 94
- 18
- Capital Work in Progress
- 0
- 0
- 46
- 0
- Cash & Bank
- 10
- 19
- Total Assets
- 94
- Total Debt
- 56
- Net Working Capital
- 4
- Contingent Liabilities
- 2
- Book Value per Share
- 14.71
- Face Value
- 10.00
- Total Debt
- 56
- Net Working Capital
- 4
- Contingent Liabilities
- 2
- Book Value per Share
- 14.71
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 19
- 53
- 47
- Trade Payables
- 9
- 6
- Total Liabilities
- 134
- 33
- Capital Work in Progress
- 0
- 0
- 55
- 0
- Cash & Bank
- 12
- 33
- Total Assets
- 134
- Total Debt
- 49
- Net Working Capital
- 11
- Contingent Liabilities
- 1
- Book Value per Share
- 38.60
- Face Value
- 10.00
- Total Debt
- 49
- Net Working Capital
- 11
- Contingent Liabilities
- 1
- Book Value per Share
- 38.60
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 19
- 56
- 44
- Trade Payables
- 14
- 6
- Total Liabilities
- 138
- 37
- Capital Work in Progress
- 1
- 1
- 64
- 1
- Cash & Bank
- 6
- 28
- Total Assets
- 138
- Total Debt
- 45
- Net Working Capital
- 16
- Contingent Liabilities
- 1
- Book Value per Share
- 39.74
- Face Value
- 10.00
- Total Debt
- 45
- Net Working Capital
- 16
- Contingent Liabilities
- 1
- Book Value per Share
- 39.74
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 1 | 2 | -0 | 7 | -7 | -1 | |
| Cash from Investing | -1 | -1 | -0 | -0 | -31 | 2 |
| Cash from Financing | 1 | -0 | 5 | -4 | 39 | -7 |
| 1 | 1 | 5 | 2 | 2 | -6 | |
| Free Cash Flow | 1 | 1 | -1 | 7 | -24 | -8 |
| OCF / Net Profit | 0.91 | 3.40 | -0.22 | 1.04 | -4.24 | -0.30 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -25 |
| OCF / Net Profit | 0.91 | 3.40 | -0.22 | 1.04 | -4.24 | -0.30 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -25 |
Mar 2020
- 1
- Cash from Investing
- -1
- Cash from Financing
- 1
- 1
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 0
Mar 2021
- 2
- Cash from Investing
- -1
- Cash from Financing
- -0
- 1
- Free Cash Flow
- 1
- OCF / Net Profit
- 3.40
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.40
- Cumulative 5-Year FCF
- 0
Mar 2022
- -0
- Cash from Investing
- -0
- Cash from Financing
- 5
- 5
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- 0
Mar 2023
- 7
- Cash from Investing
- -0
- Cash from Financing
- -4
- 2
- Free Cash Flow
- 7
- OCF / Net Profit
- 1.04
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.04
- Cumulative 5-Year FCF
- 0
Mar 2024
- -7
- Cash from Investing
- -31
- Cash from Financing
- 39
- 2
- Free Cash Flow
- -24
- OCF / Net Profit
- -4.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.24
- Cumulative 5-Year FCF
- 0
Mar 2025
- -1
- Cash from Investing
- 2
- Cash from Financing
- -7
- -6
- Free Cash Flow
- -8
- OCF / Net Profit
- -0.30
- Cumulative 5-Year FCF
- -25
- OCF / Net Profit
- -0.30
- Cumulative 5-Year FCF
- -25
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - |
| EPS (₹) | 14.06 | 6.08 | 14.47 | 4.93 | 0.91 | 1.21 |
| Book Value (₹) | 96.89 | 102.96 | 117.44 | 14.71 | 38.60 | 39.74 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 |
| Cash EPS (₹) | 25.21 | 15.27 | 22.30 | 5.62 | 1.90 | 2.94 |
| PROFITABILITY | - | - | - | - | - | - |
| Operating Margin % | 3.61% | 3.74% | 4.34% | 6.54% | 2.69% | 2.25% |
| Net Margin % | 0.58% | 0.31% | 0.61% | 2.27% | 0.53% | 0.70% |
| ROE % | 14.51% | 6.08% | 13.13% | 40.22% | 3.67% | 3.09% |
| ROCE % | 21.05% | 15.75% | 18.29% | 26.08% | 8.60% | 6.65% |
| 2.92% | 1.16% | 2.24% | 7.62% | 1.49% | 1.67% | |
| EFFICIENCY | - | - | - | - | - | - |
| Debtor Days | 1 | 1 | 0 | 0 | 0 | 1 |
| Inventory Days | 26 | 37 | 43 | 52 | 57 | 67 |
| Payable Days | 19 | 22 | 19 | 18 | 14 | 16 |
| 8 | 16 | 25 | 34 | 44 | 52 | |
| FINANCIAL HEALTH | - | - | - | - | - | - |
| Debt to Equity (x) | 2.66x | 3.29x | 3.87x | 2.78x | 0.68x | 0.61x |
| Interest Coverage (x) | 1.39x | 1.22x | 1.30x | 2.16x | 1.47x | 1.54x |
| 1.35x | 1.08x | 1.01x | 1.08x | 1.18x | 1.26x | |
| GROWTH | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | -19.65% | 20.69% | 9.85% | 8.65% | 1.08% |
| Operating Profit Growth % | 0.00% | -16.70% | 39.94% | 65.73% | -46.62% | -14.08% |
| Net Profit Growth % | 0.00% | -56.80% | 138.21% | 308.50% | -74.82% | 33.56% |
| 0.00% | 0.00% | 0.00% | 0.00% | -81.60% | 33.56% | |
| VALUATION | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 35.48x | 13.18x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.83x | 0.40x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.78% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 9.38x | 7.73x |
Mar 2020
- EPS (₹)
- 14.06
- Book Value (₹)
- 96.89
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 25.21
- Operating Margin %
- 3.61%
- Net Margin %
- 0.58%
- ROE %
- 14.51%
- ROCE %
- 21.05%
- 2.92%
- Debtor Days
- 1
- Inventory Days
- 26
- Payable Days
- 19
- 8
- Debt to Equity (x)
- 2.66x
- Interest Coverage (x)
- 1.39x
- 1.35x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.08
- Book Value (₹)
- 102.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.27
- Operating Margin %
- 3.74%
- Net Margin %
- 0.31%
- ROE %
- 6.08%
- ROCE %
- 15.75%
- 1.16%
- Debtor Days
- 1
- Inventory Days
- 37
- Payable Days
- 22
- 16
- Debt to Equity (x)
- 3.29x
- Interest Coverage (x)
- 1.22x
- 1.08x
- Revenue Growth %
- -19.65%
- Operating Profit Growth %
- -16.70%
- Net Profit Growth %
- -56.80%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 14.47
- Book Value (₹)
- 117.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 22.30
- Operating Margin %
- 4.34%
- Net Margin %
- 0.61%
- ROE %
- 13.13%
- ROCE %
- 18.29%
- 2.24%
- Debtor Days
- 0
- Inventory Days
- 43
- Payable Days
- 19
- 25
- Debt to Equity (x)
- 3.87x
- Interest Coverage (x)
- 1.30x
- 1.01x
- Revenue Growth %
- 20.69%
- Operating Profit Growth %
- 39.94%
- Net Profit Growth %
- 138.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 4.93
- Book Value (₹)
- 14.71
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.62
- Operating Margin %
- 6.54%
- Net Margin %
- 2.27%
- ROE %
- 40.22%
- ROCE %
- 26.08%
- 7.62%
- Debtor Days
- 0
- Inventory Days
- 52
- Payable Days
- 18
- 34
- Debt to Equity (x)
- 2.78x
- Interest Coverage (x)
- 2.16x
- 1.08x
- Revenue Growth %
- 9.85%
- Operating Profit Growth %
- 65.73%
- Net Profit Growth %
- 308.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.91
- Book Value (₹)
- 38.60
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 1.90
- Operating Margin %
- 2.69%
- Net Margin %
- 0.53%
- ROE %
- 3.67%
- ROCE %
- 8.60%
- 1.49%
- Debtor Days
- 0
- Inventory Days
- 57
- Payable Days
- 14
- 44
- Debt to Equity (x)
- 0.68x
- Interest Coverage (x)
- 1.47x
- 1.18x
- Revenue Growth %
- 8.65%
- Operating Profit Growth %
- -46.62%
- Net Profit Growth %
- -74.82%
- -81.60%
- P/E (x)
- 35.48x
- P/B (x)
- 0.83x
- Dividend Yield %
- 0.78%
- 9.38x
Mar 2025
- EPS (₹)
- 1.21
- Book Value (₹)
- 39.74
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.94
- Operating Margin %
- 2.25%
- Net Margin %
- 0.70%
- ROE %
- 3.09%
- ROCE %
- 6.65%
- 1.67%
- Debtor Days
- 1
- Inventory Days
- 67
- Payable Days
- 16
- 52
- Debt to Equity (x)
- 0.61x
- Interest Coverage (x)
- 1.54x
- 1.26x
- Revenue Growth %
- 1.08%
- Operating Profit Growth %
- -14.08%
- Net Profit Growth %
- 33.56%
- 33.56%
- P/E (x)
- 13.18x
- P/B (x)
- 0.40x
- Dividend Yield %
- 0.00%
- 7.73x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.